Principal Financial Group
KNTE

Principal Financial Group’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Principal Financial Group’s Portfolio KNTE Stock Details KNTE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,135
Closed -$69.6K – 2527
2023
Q1 		$69.6K Buy
11,135
+892
+9% +$5.58K ﹤0.01% 2345
2022
Q4 		$62.5K Buy
+10,243
New +$62.5K ﹤0.01% 2348